Yet, following streptozotocin (STZ) treatment, which reduces β cell numbers and causes hyperglycemia, transgenic mice exhibited an increase in insulin-positive area/islet and insulin-positive cells/islet compared with WT mice. The gene discussed is INS; the disease is Hyperglycemia.